News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24
Photo taken from Agenus/LinkedIn
Sep 10, 2024, 13:38

Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

“The Agenus team is headed to Barcelona for ESMO24.

This Friday, catch the latest data from our clinical trial of botensilimab and balstilimab in refractory sarcomas.

View the presentation details here.”

Proceed to video attached to post.
Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab cancer ESMO ESMO24 OncoDaily Oncology refractory sarcomas
Special Coverage
Blog
May 9, 2025, 14:34
Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Blog
May 9, 2025, 14:19
Josh Thomas Georgy Highlights DESTINY-Breast11 Results in High-Risk HER2+ Early Breast Cancer
Blog
May 9, 2025, 14:18
Half of Patients Diagnosed With Cancer in 2023 Had a History of Smoking - CRI
Blog
May 9, 2025, 14:08
Aligning Incentives for Value-Based Success: Building Sustainable Oncology Partnerships - CancerX
Blog
May 9, 2025, 14:06
Childhood Cancer at Survivor’s Week 2025: A Celebration of Strength and New Beginnings
Blog
May 9, 2025, 14:01
Meet the ASCO25 Featured Voices
Blog
May 9, 2025, 13:59
Arturo LoAIza-Bonilla: How AI and Digital Platforms are Transforming Patient Adherence and Real-Time Decision Support
Insight
May 9, 2025, 13:55
FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot
Blog
May 9, 2025, 13:49
Fernando Goldsztein: A Time to Raise Awareness about Brain Tumors
Blog
May 9, 2025, 13:46
Small Cell Lung Cancer Progress: Insights from LUNGevity's Executive Director
Blog
May 9, 2025, 13:37
Helena Linardou: Exciting afternoon at the 2025 AI for Oncology Congress
Opinion
May 9, 2025, 13:29
Galip Can Uyar: Prophylactic oophorectomy boosts survival by up to 50% in young women with BRCA mutations